Who should attend:

• Cardiovascular specialists
• Internists
• Allied health professionals
• Heart failure care teams
• Cardiovascular Trainees, Residents and Fellows
• Basic scientist interested in CV disease
• Primary care providers

Objectives

The overall goal of this symposium is to promote the exchange of existing knowledge from innovative cellular research, through translation, to foster dissemination and collaboration, leading to better cardiovascular outcomes.

Upon completion of this program participants should be able to:

• Identify key updates, recommendations, and changes in hypertension management and treatment strategies outlined in the guidelines
• Analyze emerging research and evidence suggesting the need for a paradigm shift in the approach to brain and heart care
• Identify the relevant advances and highlight promising research concerning the interaction between exercise and cognition
• Define common conditions of brain-heart related disorders and discuss therapeutic treatment options
• Discuss the positive and negative impact of mental wellness on brain heart health
• Recognize the interconnectedness between brain health and heart health, and understand the implications of this relationship for overall well-being
• Review the direct and indirect mechanism of Cannabis on brain and heart function
• Review the evolving research and evidence regarding marijuana use and its effects on brain and heart health, incorporating new findings into clinical practice to optimize patient care and outcomes
• Recognize the importance of assessing cognitive function
• Summarize steps for quick cognitive screening in the office setting
• Identify best practices for the management of patients with ischemic heart disease
• Evaluate the implications of the ORBITA-2 trial results on current clinical practice guidelines for the management of stable angina
• Determine best treatment options for patients with Mitral and Tricuspid valve disease
• Analyze the evolution of transcutaneous interventions for mitral and tricuspid valve disease, including the development of novel techniques and devices
• Recognize and understand the burden of obesity and the cardiovascular impact with the utilization of novel therapies for weight reduction
• Evaluate the implications of the STEP-HFpEF trial in patients with obesity and HFpEF in relation to the safety and efficacy
• Review best treatment options of an integrated approach to assessment and managing psychological care in severe obesity
• Choose optimal LDL lowering agents to reduce plaque burden in patients with CV disease
• Evaluate how AI can Enhance Diagnosis and Prognosis through ECG Analysis
• Identify the challenges and barriers to the adoption of AI in medicine, including data privacy concerns, regulatory issues, and integration with existing clinical workflows
• Discuss the role of artificial intelligence (AI) in medical imaging, including image analysis, interpretation, and decision support
• Explain cardiac dyssynchrony and options for optimal resynchronization therapy for patients with heart failure
• Review the strengths and limitations of different devices used to detect arrhythmias
• Evaluate the efficacy and safety of atrial fibrillation ablation procedures, based on available clinical trial data, meta-analyses, and real-world experience
• Review various rheumatological diseases that can affect the heart and learn how to investigate and manage patients with elevated CV risks
• Discuss the treatment strategy for patients with amyloidosis including disease modifying therapies
• Discuss the complex phenotypic presentation of HCM and treatment options
• Describe the emerging therapies in the management of Diabetic Kidney Disease, benefits, indications and limitations.